These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 626990)

  • 1. Separation and identification of impurities in parenteral methotrexate dosage forms.
    Hignite CE; Shen DD; Azarnoff DL
    Cancer Treat Rep; 1978 Jan; 62(1):13-8. PubMed ID: 626990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
    Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
    J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and quantitation of methotrexate and methotrexate metabolites in clinical high-dose therapy by high pressure liquid chromatography and field desorption mass spectrometry.
    Przybylski M; Preiss J; Dennebaum R; Fischer J
    Biomed Mass Spectrom; 1982 Jan; 9(1):22-32. PubMed ID: 7037062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.
    Iven H; Bartels H
    Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of degradation impurities in epirubicin hydrochloride injection.
    Kumar D; Tomar RS; Deolia SK; Srivastava R; Mitra M; Tyagi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):45-53. PubMed ID: 18539101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N10-methylpteroic acid in biological fluids by liquid chromatography with fluorimetric detection.
    Salamoun J; Frantisek J
    J Chromatogr; 1986 May; 378(1):173-81. PubMed ID: 3733970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the chiral and achiral related substances of methotrexate by cyclodextrin-modified micellar electrokinetic chromatography.
    Gotti R; El-Hady DA; Andrisano V; Bertucci C; El-Maali NA; Cavrini V
    Electrophoresis; 2004 Aug; 25(16):2830-7. PubMed ID: 15352016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
    Przybylski M
    Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexate.
    Donehower RC; Hande KR; Drake JC; Chabner BA
    Clin Pharmacol Ther; 1979 Jul; 26(1):63-72. PubMed ID: 445963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of methotrexate and 7-hydroxymethotrexate by high-pressure liquid chromatography.
    Wisnicki JL; Tong WP; Ludlum DB
    Cancer Treat Rep; 1978 Apr; 62(4):529-32. PubMed ID: 657149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of methotrexate and its impurities and metabolites with high performance liquid chromatography].
    Labat C; Mansour K; Malmary MF; Casanovas AM; Oustrin J
    J Pharm Belg; 1986; 41(1):29-34. PubMed ID: 3701565
    [No Abstract]   [Full Text] [Related]  

  • 15. Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
    Zhou H; Tai Y; Sun C; Pan Y
    J Pharm Biomed Anal; 2005 Feb; 37(1):97-107. PubMed ID: 15664748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the metabolism of methotrexate. II. Isolation and identification of several unconjugated aminopteridines as metabolites in the rat.
    Valerino DM
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):529-42. PubMed ID: 4638591
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Column liquid chromatography of methotrexate and its metabolites using a post-column photochemical reactor and fluorescence detection.
    Salamoun J; Smrz M; Kiss F; Salamounová A
    J Chromatogr; 1987 Aug; 419():213-23. PubMed ID: 3667779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo methotrexate kinetics and metabolism in human hematopoietic cells. Clinical significance of methotrexate concentrations in erythrocytes.
    Schrøder H
    Dan Med Bull; 1990 Feb; 37(1):22-40. PubMed ID: 2178886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.